What is the role of point-of-care ultrasound (PoCUS) in the diagnosis and early monitoring of cardiogenic shock in the emergency department?

PoCUS is Essential for Rapid Diagnosis and Hemodynamic Monitoring of Cardiogenic Shock in the Emergency Department

Point-of-care ultrasound should be used routinely in the emergency department for both diagnosing cardiogenic shock and guiding its early management, as it improves diagnostic accuracy, enables real-time hemodynamic assessment, and carries minimal risk compared to invasive alternatives like pulmonary artery catheters. 1

Diagnostic Role: Confirming Cardiogenic Shock

PoCUS significantly improves diagnostic accuracy in undifferentiated shock presentations. The evidence demonstrates:

• Diagnostic accuracy of 96.3% for cardiogenic shock when using structured protocols like RUSH (Rapid Ultrasound in Shock and Hypotension) 2
• PoCUS increases the correctness of diagnosis in acute dyspnea and shock states compared to standard diagnostic pathways alone 3
• The 2025 Society of Critical Care Medicine guidelines conditionally recommend CCUS (critical care ultrasound) for cardiogenic shock management, noting minimal adverse events and superior safety compared to pulmonary artery catheters 1

Key Diagnostic Elements to Assess:

Cardiac evaluation should identify:

• Left and right ventricular systolic function
• Valvular pathology (acute mitral regurgitation, aortic stenosis)
• Mechanical complications of myocardial infarction (ventricular septal defect, free wall rupture, pseudoaneurysm)
• Pericardial effusion and tamponade physiology
• Right heart strain patterns suggesting pulmonary embolism 4, 5

Differentiation from other shock types:

• Obstructive shock: 100% diagnostic accuracy for identifying pericardial tamponade, massive PE 2
• Hypovolemic shock: IVC assessment shows collapsed, hyperresponsive vessel
• Distributive shock: hyperdynamic ventricles with elevated cardiac output (though only 75% accuracy) 2

Hemodynamic Monitoring Role

PoCUS enables serial physiological assessment without the risks of invasive monitoring. The most clinically useful parameters include:

Volume Status and Fluid Responsiveness:

• LVOT VTI (left ventricular outflow tract velocity-time integral): Serves as a reproducible surrogate of stroke volume and cardiac output 6, 7, 8

  • Baseline measurement establishes cardiac output

  • 10-15% increase with passive leg raise or fluid bolus indicates fluid responsiveness

  • Serial measurements track response to therapy

• IVC assessment: Provides complementary volume status information, though less reliable as sole predictor of fluid responsiveness 6

Congestion Assessment:

• Lung ultrasound for B-lines: Detects and quantifies pulmonary edema with superior accuracy to chest X-ray 8

  • ≥3 B-lines per intercostal space in ≥2 zones bilaterally indicates pulmonary congestion
  • Serial assessment tracks diuresis response

• Venous Excess Ultrasound Score (VExUS): Evaluates systemic venous congestion through hepatic, portal, and intrarenal venous Doppler patterns 8

  • Identifies patients at risk for poor tolerance to fluid administration
  • Guides decongestive therapy intensity

Cardiac Output Monitoring:

• LVOT VTI or RVOT VTI measurements enable beat-to-beat assessment of forward flow 6
• Elevated values suggest distributive component
• Reduced values with poor augmentation to interventions indicate need for inotropic support

Practical Implementation Algorithm

Initial Assessment (within 5-15 minutes of presentation):

1. Cardiac windows: Identify ventricular function, valvular disease, mechanical complications
2. IVC assessment: Gauge volume status
3. Lung zones: Quantify B-lines for pulmonary congestion
4. Aorta/pericardium: Rule out dissection, tamponade

Ongoing Monitoring (every 1-4 hours depending on stability):

1. LVOT VTI measurements before and after therapeutic interventions
2. Lung ultrasound to track congestion response to diuresis
3. Venous Doppler if concern for systemic congestion persists
4. Cardiac function reassessment if clinical deterioration occurs

Integration with SCAI Staging

The 2026 narrative review emphasizes integrating PoCUS findings with SCAI (Society for Cardiovascular Angiography and Interventions) shock stages 4:

• SCAI Stage C-E patients: Require more frequent PoCUS assessments (every 1-2 hours)
• Mechanical circulatory support decisions: Guided by persistent low LVOT VTI despite maximal medical therapy
• Prognosis: Severe biventricular dysfunction, persistent venous congestion, and lack of VTI improvement predict poor outcomes

Critical Caveats

Operator dependence remains the primary limitation 1, 4. Misinterpretation risks include:

• Mistaking regional wall motion abnormalities for global dysfunction
• Inadequate acoustic windows in obese patients or those with emphysema
• Overreliance on single parameters rather than integrating multiple findings

PoCUS complements but does not replace invasive monitoring in all cases. The 2025 SCCM guidelines note that cardiogenic shock patients receiving mechanical circulatory support or post-heart transplant may still benefit from pulmonary artery catheters 1.

Training requirements: Structured protocols and competency-based training are essential before independent use 3, 1.

Evidence Strength Considerations

The recommendation is based on:

• Strong guideline support: 2025 SCCM guidelines conditionally recommend CCUS for cardiogenic shock 1
• Consistent diagnostic accuracy: Multiple studies demonstrate >90% accuracy for cardiogenic shock identification 2
• Safety profile: No significant adverse events reported with POCUS use, contrasting with PAC complications 1
• Mortality signal: Low-certainty evidence suggests CCUS may reduce mortality (RR 0.80) in critically ill patients 1

The evidence is strongest for diagnosis and weakest for demonstrating direct mortality benefit, though the risk-benefit ratio strongly favors PoCUS use given its non-invasive nature and the high mortality of untreated or mismanaged cardiogenic shock.